Thomas Schrader
13Patents
2h-index
35Co-inventors
50Inventor score
Filing activity: Oct 29, 2004 → Jul 25, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9085581B2 | Processes for the preparation of S1P1 receptor modulators and crystalline forms thereof | Human Necessities | 6 | Active |
| US11512090B2 | Muscarinic acetylcholine M1 receptor antagonists | Chemistry; Metallurgy | 3 | Active |
| US11752149B2 | Muscarinic acetylcholine M1 receptor antagonists | Chemistry; Metallurgy | 2 | Active |
| US7241792B2 | Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereof | Chemistry; Metallurgy | 2 | Expired |
| US8791092B2 | Molecular tweezers for the treatment of amyloid-related diseases | Chemistry; Metallurgy | 1 | Active |
| US12054487B2 | Muscarinic acetylcholine M1 receptor antagonists | Chemistry; Metallurgy | 1 | Active |
| US10836764B2 | 5-HT2C receptor agonists and compositions and methods of use | Human Necessities | 1 | Active |
| US8637555B2 | Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof | Chemistry; Metallurgy | 0 | Active |
| US8481494B2 | Compounds for the treatment of diseases related to protein misfolding | Human Necessities | 0 | Active |
| US12390462B2 | Muscarinic acetylcholine M1 receptor antagonists | Chemistry; Metallurgy | 0 | Active |
| US8507473B2 | 3H-imidazo[4,5-b]pyridin-5-ol derivatives useful in the treatment of GPR81 receptor disorders | Human Necessities | 0 | Active |
| US11608339B2 | 5-HT2C receptor agonists and compositions and methods of use | Human Necessities | 0 | Active |
| US7612106B2 | Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.